H4951

To address barriers to HIV prevention medication

Introduced·1/28/26
Introduced Text

Massachusetts H4951 aims to eliminate barriers to HIV prevention medication by ensuring comprehensive coverage and access.

Massachusetts H4951 seeks to address barriers to HIV prevention medication by mandating that health insurance plans, including those issued by the Group Insurance Commission, provide coverage for HIV prevention drugs without cost-sharing or restrictive protocols. It also prohibits plans from denying prescriptions based on the type of health care practitioner or practice setting, as long as the practitioner is licensed. The bill extends these requirements to health maintenance organizations, preferred provider organizations, and carriers.

Included in complete analysis

  • Overview
  • Core Provisions
  • Implementation
  • Impact
  • Legal Framework
  • Critical Issues

See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.

Where it stands

Current
Ways and Means Committee
Next
Committee decision

Sponsors

0
0
Democratic CaucusRepublican Caucus

History

Jul 27

House

Committee recommended bill ought to pass and referred to the committee on House Ways and Means

Jul 9

House

Reporting date extended to Thursday, December 31, 2026

Jan 28

House

Reported from the committee on Financial Services